Bristol Gate Capital Partners Inc. Has $94.18 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bristol Gate Capital Partners Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 184,925 shares of the healthcare conglomerate’s stock after buying an additional 12,372 shares during the period. UnitedHealth Group makes up about 4.7% of Bristol Gate Capital Partners Inc.’s holdings, making the stock its 7th largest holding. Bristol Gate Capital Partners Inc.’s holdings in UnitedHealth Group were worth $94,175,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Swedbank AB purchased a new stake in UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after buying an additional 1,196,758 shares in the last quarter. Dimensional Fund Advisors LP grew its position in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. Baillie Gifford & Co. raised its position in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado boosted its holdings in shares of UnitedHealth Group by 3,464.9% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after purchasing an additional 802,160 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. HSBC upped their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $614.17.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Down 0.6 %

Shares of UnitedHealth Group stock opened at $577.10 on Friday. The company’s fifty day simple moving average is $575.84 and its two-hundred day simple moving average is $519.83. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market cap of $532.91 billion, a P/E ratio of 35.28, a PEG ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the business posted $6.14 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.